Trial Details
COMPLETEDBasic Information
| Clinical ID | c1597 |
|---|---|
| Identifier | NCT01903252 |
| Trial Title | TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Acute Ulcerative Colitis |
| Interventions | DRUG: TP05|DRUG: Asacol 400 mg |
Participant Information
| Sponsor | Tillotts Pharma AG |
|---|---|
| City | Rheinfelden |
| Country/Region | Switzerland |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-07-13 |
|---|---|
| Primary Completion Date | 2025-05-16 |
| Completion Date | 2025-11-16 |